Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation-Reference-Cited by-同舟云学术

Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation

Published:1995-07 Issue:3 Volume:50 Page:381-390
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Hobbs Gregory A.,Keilbaugh Sue A.,Rief Pamela M.,Simpson Melvin V.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference28 articles.

1. Involvement of DNA polymerase α in simian virus 40 DNA replication;Edenberg;J Biol Chem,1978

2. Mitochondrial DNA replication does not involve DNA polymerase α;Zimmermann;J Biol Chem,1980

3. Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication;Simpson;Biochem Pharmacol,1989

4. Role of mtDNA replication in the toxicity of 3′-azido-3′-deoxythymidine (AZT) in AIDS therapy and studies on other anti-HIV-1 dideoxynucleosides;Keilbaugh,1990

5. The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs;Keilbaugh;Biochem Pharmacol,1991

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial dysfunction in HIV-induced peripheral neuropathy;International Review of Neurobiology;2019

2. Neurotoxic effects of AZT on developing and adult neurogenesis;Frontiers in Neuroscience;2015-03-20

3. An Analysis of Enzyme Kinetics Data for Mitochondrial DNA Strand Termination by Nucleoside Reverse Transcription Inhibitors;PLoS Computational Biology;2009-01-09

4. Synthesis, Characterization, and In Vitro Assay of Folic Acid Conjugates of 3′-Azido-3′-Deoxythymidine (AZT): Toward Targeted AZT Based Anticancer Therapeutics;Nucleosides, Nucleotides and Nucleic Acids;2008-01-18

5. Mitochondrial Toxicity of Tenofovir, Emtricitabine and Abacavir Alone and in Combination with Additional Nucleoside Reverse Transcriptase Inhibitors;Antiviral Therapy;2007-10